Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52.3M
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
22.1M
-
Shares change
-
+186K
-
Total reported value, excl. options
-
$101M
-
Value change
-
+$845K
-
Put/Call ratio
-
0
-
Number of buys
-
46
-
Number of sells
-
-31
-
Price
-
$4.55
Significant Holders of ENZO BIOCHEM INC - Common Stock (ENZB) as of Q1 2016
101 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock as of Q1 2016.
ENZO BIOCHEM INC - Common Stock (ENZB) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.1M shares
of 52.3M outstanding shares and own 42.34% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4.34M shares), First Light Asset Management, LLC (1.73M shares), DIMENSIONAL FUND ADVISORS LP (1.68M shares), RENAISSANCE TECHNOLOGIES LLC (1.45M shares), ACADIAN ASSET MANAGEMENT LLC (1.34M shares), VANGUARD GROUP INC (1.34M shares), BlackRock Institutional Trust Company, N.A. (1.31M shares), MANUFACTURERS LIFE INSURANCE COMPANY, THE (910K shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (884K shares), and Lone Star Value Management LLC (575K shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.